Cinnamon effects on blood pressure and metabolic profile: A double-blind, randomized, placebo-controlled trial in patients with stage 1 hypertension | ||
Avicenna Journal of Phytomedicine | ||
دوره 11، شماره 1، فروردین و اردیبهشت 2021، صفحه 91-100 اصل مقاله (604.23 K) | ||
نوع مقاله: Original Research Article | ||
شناسه دیجیتال (DOI): 10.22038/ajp.2020.16138 | ||
نویسندگان | ||
Fatemeh Shirzad1؛ Negar Morovatdar2؛ Ramin Rezaee3؛ Konstantinos Tsarouhas4؛ Alireza Abdollahi Moghaddam* 5 | ||
1Department of Cardiology, Emam Reza Educational Center, Mashhad University of Medical Sciences, Mashhad, Iran. | ||
2Clinical Research Development Unit, Imam Reza Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran | ||
3Clinical Research Development Unit, Imam Reza Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. 3 Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. | ||
4Department of Cardiology, University Hospital of Larissa, Larissa, Greece. Center for Adolescent Medicine and UNESCO Chair on Adolescent Health Care, First Department of Pediatrics, Medical School, National and Kapodistrian University | ||
5Department of Cardiology, Emam Reza Educational Center, Mashhad University of Medical Sciences, Mashhad, Iran | ||
چکیده | ||
Objective: Cinnamon effect on blood pressure remains controversial. The present pilot study assessed cinnamon effect on blood pressure, and metabolic profile of stage 1 hypertension patients (S1HTN). Materials and Methods: This double-blind placebo-controlled randomized trial was conducted between June and October 2019, in Mashhad, Iran. Study inclusion criteria comprised S1HTN diagnosis, based on 24-hour ambulatory blood pressure monitoring (ABPM). Subjects were randomly assigned to two groups: cinnamon group (capsule, 1500 mg/day, 90 days) and placebo group. On days 0 and 90, ABPM derived systolic and diastolic blood pressure (SBP and DBP, respectively), blood lipid profile, and fasting blood sugar (FBS) were recorded. Results: The two groups did not differ significantly regarding vascular risk factors, educational status, lipid profile and blood pressure at baseline, except for lower HDL-c in cinnamon group (p=0.03). On day 90, there was no significant difference between two study groups for lipid profile and blood pressure. A statistically significant decrease in mean 24-hr SBP and mean day SBP was observed in the cinnamon group, while mean night SBP and mean night DBP were decreased significantly in the placebo group after 90 days. A statistically significant decrease in mean change of day value of SBP was found in the cinnamon group, compared to the placebo. On day 90, FBS remained practically unchanged but a significant increase in HDL-c (5.8 unit; p=0.01) and a significant decrease in LDL-c levels (17.7 unit; p=0.009) were observed in the cinnamon group compared to placebo group. Conclusion: Cinnamon caused a statistically significant decrease in mean ambulatory SBP but in a clinically moderate way, and lipid profile was significantly improved. Therefore, cinnamon might be considered a complementary treatment in subjects with S1HTN. | ||
کلیدواژهها | ||
cinnamon؛ hypertension؛ cholesterol؛ HDL؛ LDL | ||
مراجع | ||
Ajebli M, Eddouks M. 2019. Phytotherapy of hypertension: An updated overview. Endocr Metab Immune Disord Drug Targets, doi: 10.2174/1871530320666191227104648. Akilen R, Pimlott Z, Tsiami A, Robinson N3 20133 Effect of short-term administration of cinnamon on blood pressure in patients with prediabetes and type 2 diabetes. Nutrition, 29:1192-11963 Allen RW, Schwartzman E, Baker WL, Coleman CI, Phung OJ. 2013. Cinnamon use in type 2 diabetes: an updated systematic review and meta-analysis. Ann Fam Med, 11:452-459. Archer AW. 1988. Determination of cinnamaldehyde, coumarin and cinnamyl alcohol in cinnamon and cassia by highperformance liquid chromatography. J Chromatogr A, 447:272-276. Askari F, Rashidkhani B, Hekmatdoost A. 2014. Cinnamon may have therapeutic benefits on lipid profile, liver enzymes, insulin resistance, and high-sensitivity Creactive protein in nonalcoholic fatty liver disease patients. Nutr Res, 34:143-148. Azimi P, Ghiasvand R, Feizi A, Hosseinzadeh J, Bahreynian M, Hariri M, KhosraviBoroujeni H. 2016. Effect of cinnamon, cardamom, saffron and ginger consumption on blood pressure and a marker of endothelial function in patients with type 2 diabetes mellitus: A randomized controlled clinical trial. Blood Press, 25:133-140. Bonaa K. 1991. Association between blood pressure and serum lipids in population. The Troms ø Study. Circulation, 83:1305- 1314. Brook RD, Rajagopalan S. 2018. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/AP hA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Soc Hypertens, 12:238. El-Bassossy HM, Fahmy A, Badawy D. 2011. Cinnamon against stage 1 hypertension AJP, Vol. 11, No. 1, Jan-Feb 2021 99 Cinnamaldehyde protects from the hypertension associated with diabetes. Food Chem Toxicol, 49:3007-3012. Gruenwald J, Freder J, Armbruester N. 2010. Cinnamon and health. Crit Rev Food Sci Nut, 50:822-834. Han X, Parker TL. 2017. Antiinflammatory activity of cinnamon (Cinnamomum zeylanicum) bark essential oil in a human skin disease model. Phytother Res, 31:1034-1038. Harada M, Yano S. 1975. Pharmacological studies on Chinese cinnamon. II. Effects of cinnamaldehyde on the cardiovascular and digestive systems. Chem Pharm Bull, 23:941-947. Hong J-W, Yang G-E, Kim YB, Eom SH, Lew J-H, Kang H. 2012. Anti-inflammatory activity of cinnamon water extract in vivo and in vitro LPS-induced models. BMC Complement Altern Med, 12:237. IM KK, Issac A, Ninan E, Kuttan R, Maliakel B. 2014. Enhanced anti-diabetic activity of polyphenol-rich de-coumarinated extracts of Cinnamomum cassia. J Funct Foods, 10:54-64. Jain SG, Puri S, Misra A, Gulati S, Mani K. 2017. Effect of oral cinnamon intervention on metabolic profile and body composition of Asian Indians with metabolic syndrome: a randomized double-blind control trial. Lipids Health Di, 16:1-11. Jayaprakasha G, Rao LJM. 2011. Chemistry, biogenesis, and biological activities of Cinnamomum zeylanicum. Crit Rev Food Sci Nutr, 51:547-562. Kawatra P, Rajagopalan R. 2015. Cinnamon: Mystic powers of a minute ingredient. Pharmacognosy Res, 7(Suppl 1):S1. Khan A, Safdar M, Khan MMA, Khattak KN, Anderson RA. 2003. Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes care, 26:3215-3218. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. 2002. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet, 360:1903-1913. Ma YH, Leng XY, Dong Y, Xu W, Cao XP, Ji X, Wang HF, Tan L, Yu JT. 2019. Risk factors for intracranial atherosclerosis: A systematic review and meta-analysis. Atherosclerosis, 281:71-77. Maierean SM, Serban MC, Sahebkar A, Ursoniu S, Serban A, Penson P, Banach M; Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group. 2017. The effects of cinnamon supplementation on blood lipid concentrations: A systematic review and meta-analysis. J Clin Lipidol, 11:1393-1406. Medagama AB. 2015. The glycaemic outcomes of Cinnamon, a review of the experimental evidence and clinical trials. Nutr J, 14:108 Morovatdar N, Tayebi Nasrabad G, Tsarouhas K, Rezaee R. 2019. Etiology of Renal Replacement Therapy in Iran. Int J Nephrol, 2019: 1-5. Mousavi SM, Karimi E, Hajishafiee M, Milajerdi A, Amini MR, Esmaillzadeh A. 2019a. Anti-hypertensive effects of cinnamon supplementation in adults: A systematic review and dose-response Metaanalysis of randomized controlled trials. Crit Rev Food Sci Nutr, 16:1-11. Mousavi SM, Rahmani J, Kord-Varkaneh H, Sheikhi A, Larijani B, Esmaillzadeh A. 2019b. Cinnamon supplementation positively affects obesity: A systematic review and dose-response meta-analysis of randomized controlled trials. Clin Nut, 39:123-133. Nam J, Park Y, Kim MS, Kim JY. 2019. Antiinflammatory Effects of Cinnamon Extracts on an Animal Model of Intestinal Inflammation, (P06-088-19). Oxford University Press. Nyadjeu P, Dongmo A, Nguelefack TB, Kamanyi A. 2011. Antihypertensive and vasorelaxant effects of Cinnamomum zeylanicum stem bark aqueous extract in rats. J Complement Integr Med, 8: 1-18 Pan H, Hibino M, Kobeissi E, Aune D. 2019. Blood pressure, hypertension and the risk of sudden cardiac death: a systematic review and meta-analysis of cohort studies. Eur J Epidemiol, doi:10.1007/s10654-019- 00593-4. Poorzand H, Tsarouhas K, Hozhabrossadati SA, Khorrampazhouh N, Bondarsahebi Y, Bacopoulou F, Rezaee R, Jafarzadeh Esfehani R, Morovatdar N. 2019. Risk factors of premature coronary artery disease in Iran: A systematic review and meta‐analysis. Eur J Clin Invest, 49: 1-13. Ranasinghe P, Pigera S, Premakumara GS, Galappaththy P, Constantine GR, Katulanda P. 2013. Medicinal properties of ‘true’cinnamon (Cinnamomum Shirzad et al. AJP, Vol. 11, No. 1, Jan-Feb 2021 100 zeylanicum): a systematic review. BMC Complement Altern Med, 13:1-10. Schulz KF, Altman DG, Moher D. 2010. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMC Med, 8:18. Thomopoulos C, Parati G, Zanchetti A. 2014. Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and metaregression analyses of randomized trials. J Hypertens, 32:2285-2295. Vafa M, Mohammadi F, Shidfar F, Sormaghi MS, Heidari I, Golestan B, Amiri F. 2012. Effects of cinnamon consumption on glycemic status, lipid profile and body composition in type 2 diabetic patients. Int J Prev Med, 3:531-536. Wainstein J, Stern N, Heller S, Boaz M. 2011. Dietary cinnamon supplementation and changes in systolic blood pressure in subjects with type 2 diabetes. J Med Food, 14:1505-1510. Wansi SL, Nyadjeu P, Ngamga D, Mbuyo E, Nguelefack T, Kamanyi A. 2007. Blood pressure lowering effect of the ethanol extract from the stembark of cinnamomum zeylanicum (lauraceae) in rats. Pharmacol online, 3:166-176. Whelton PK, Carey RM, Aronow WS, et al. 2018 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/AP hA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol, 71:e127-e248. Wiweko B, Susanto CA. 2017. The effect of metformin and cinnamon on serum antimullerian hormone in women having PCOS: A Double-blind, randomized, controlled trial. J Hum Reprod Sci, 10:31- 36. Xue Y-L, Shi H-X, Murad F, Bian K. 2011. Vasodilatory effects of cinnamaldehyde and its mechanism of action in the rat aorta. Vasc Health Risk Manag, 7:273-280. Yano Y, Tanner RM, Sakhuja S, et al. 2019. Association of daytime and nighttime blood pressure with cardiovascular disease events among African American individuals. JAMA Cardiol, 4:910-917. Zare R, Nadjarzadeh A, Zarshenas MM, Shams M, Heydari M. 2019. Efficacy of cinnamon in patients with type II diabetes mellitus: A randomized controlled clinical trial. Clin Nutr, 38:549-556. Ziegenfuss TN, Hofheins JE, Mendel RW, Landis J, Anderson RA. 2006. Effects of a water-soluble cinnamon extract on body composition and features of the metabolic syndrome in pre-diabetic men and women. J Int Soc Sports Nutr, 3:45-53. | ||
آمار تعداد مشاهده مقاله: 17,107 تعداد دریافت فایل اصل مقاله: 4,312 |